Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
151 hedge funds and large institutions have $1.72B invested in Axonics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 13 closing their positions.
1,023% more call options, than puts
Call options by funds: $44.7M | Put options by funds: $3.98M
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
60% more capital invested
Capital invested by funds: $1.07B → $1.72B (+$647M)
53% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 40
13% more funds holding
Funds holding: 134 → 151 (+17)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$89.2M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$40.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$26.6M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$13.9M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$26.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$18.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$16.1M |
| 4 |
Millennium Management
New York
|
-$14.7M |
| 5 |
SC
Samlyn Capital
New York
|
-$12.7M |
AXNX Hedge Fund Activity: Q3 2020 in Review
151 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q3 2020, worth a combined $1.72B — up 60% from $1.07B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new AXNX positions and 13 closed out — a net gain of 17 holders — while 61 added to existing stakes and 40 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $89.2M. The largest seller was Deerfield Management, cutting an estimated $26.4M.
- 151 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q3 2020, up from 134 in Q2 2020.
- Funds reported $1.72B of Axonics, Inc. Common Stock stock for Q3 2020, up 60% quarter-over-quarter.
- 30 funds opened new Axonics, Inc. Common Stock positions in Q3 2020 and 13 closed out, a net change of +17 holders.
- The largest Axonics, Inc. Common Stock buyer in Q3 2020 was Fidelity Investments, an estimated $89.2M added.
- The largest Axonics, Inc. Common Stock seller in Q3 2020 was Deerfield Management, an estimated $26.4M sold.
Based on aggregated 13F filings for Q3 2020.